Acurx Pharmaceuticals, Inc. (GETTEX:3ZO0) Financings

Acurx Pharmaceuticals, Inc.

Financings

RaiseDate
Registered direct offering of shares of common stock (or pre-funded warrants) with concurrent unregistered short-term warrants
Closed: US$2.5M raised · US$3.03 a share · Warrants at US$2.78 for 24 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Working capital and other general corporate purposes
Apr 16, 2026
Warrant exercise of existing warrants exercised for shares of common stock
Announced: about US$2.67M · US$0.6 a share · Warrants at US$0.425 for 60 months
Use of proceeds: Working capital and general corporate purposes
Jun 17, 2025
Equity line of credit
Announced: raise
Buyers: Lincoln Park Capital (equity line of credit for up to $12 million of additional funding)
May 13, 2025
Registered direct offering of shares of common stock with unregistered short-term warrants
Closed: US$1.1M raised · US$0.4 a share · Warrants at US$0.4 for 24 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Working capital and other general corporate purposes
Mar 10, 2025
Registered direct offering of shares of common stock with unregistered warrants
Announced: about US$2.5M · US$1.015 a share · Warrants at US$0.9 for 60 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Working capital and other general corporate purposes
Jan 6, 2025

Read by 6ix AI from the company's releases